Erin Allman‑Updyke and Erin Welsh
speaker
988 appearances
1 recordings
1 series
first heard Aug 2026
last heard 4 Aug
Erin Allman‑Updyke and Erin Welsh’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Aug 2026 with 1.
Appearances
There's a lot.
There's a lot.
And we're going to get into it in a second.
But yeah.
But yeah.
But these studies, these large-scale studies that were done not just by pharmaceutical industry, they conclusively and consistently showed that statins were life-saving drugs and that they had earned their blockbuster status.
Correct.
Across the board, statins led to a 25% to 30% reduction in LDL, coronary artery disease, and death from cardiovascular disease.
Wow.
In the 40 or so years since statins have been on the market, death from cardiovascular disease has dropped by over 75 percent in many industrialized countries.
Statins are a major tool in that fight, along with big advancements in medicine, lifestyle modifications and diagnostics.
But of course, the story doesn't end here.
The potential benefits of statins are enormous, both at a population and individual level, especially with cardiovascular disease being the leading cause of death in many countries.
But increasingly, the benefits of these drugs are not realized because people aren't taking statins when it's recommended that they do.
Why is that?
Why?
As it turns out, it's for many different reasons.
A couple of recent papers looked into the issue, and they presented some themes that they found in why people either refused or discontinued statins.
There were practical and logistical considerations, so concern about taking multiple medications, polypharmacy burden.
Financial barriers, you know, having to drive to the clinic to get low-cost statins, things like that.
Showing 301–320 of 988 · page 16 of 50
← Previous
Next →